Cancer's hidden toll: young kids miss key social milestones
NCT ID NCT03086421
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how cancer and its treatment impact social and emotional development in children aged 4 to 6. About 119 children with brain or solid tumors will complete questionnaires and tasks to measure social skills, thinking abilities, and play behavior. The goal is to understand the effects of missed early social experiences, like preschool and playground time, and track changes as children grow into survivors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify social challenges in young cancer survivors, leading to better support programs.
- What could go wrong
- This is a small, early-stage observational study, so findings may not apply to all children. It does not test a treatment, so direct benefits are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
119 people
The number who actually took part.
- Started
-
Jul 2017
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be patients at St. Jude Children's Research Hospital who meet the eligibility criteria, along with their parent/legal guardian, and another adult caregiver.
- Ages
-
4 to 6 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Primary Diagnosis of a brain or non-CNS solid tumor * Between 4 and 6 years of age at enrollment * Between 6 and 12 months post-therapy at the time of enrollment * Treatment plan included chemotherapy * English speaking * Cognitive and language capacity to complete measures Exclusion Criteria: * Diagnosis of a genetic disorder/pre-existing neurodevelopmental condition associated with neurocognitive or social impairment (e.g., autism, Neurofibromatosis Type 1 (NF1), Down syndrome) * Solid tumor patients who required CNS-directed therapy (e.g., radiation, intrathecal chemotherapy) * Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brain tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One extra radiation dose after standard brain cancer therapy: can it boost the immune system?
- Zapping the brain to restore lost vision
- Brain surgery delirium: can real-time monitoring protect older patients?
- Music as medicine: could ukulele lessons rebuild young brains after cancer?
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients